~~<i id='FB1A79D0E9'><strike id='FB1A79D0E9'><tt id='FB1A79D0E9'><pre id='FB1A79D0E9'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

Wikipedia

author：comprehensive 2025-09-27 09:37:59 - browse：761

Michel Pairet -- health business coverage from STAT — Michel Pairet Courtesy Boehringer Ingelheim

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.

There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health. Oh, it was also the day the company launched another Humira biosimilar.

In other words, there was a whole lot for the company to discuss as it works to promote its breadth and build partnerships with academic researchers and other companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Living organ donors deserve priority status for transplants

knowledge

entertainment

knowledge

leisure time

knowledge

Wikipedia

DarronCummings/APLONDON—AU.K.governmentagencyonTuesdaysaidthatitwon’trecommendEliLilly’sMounjaro—par

WSS

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

Living organ donors deserve priority status for transplants

Timeline: Key moments in fight for gay rights

California wildfire smoke linked to 52,000 early deaths, study says

Cheap, fast test for Zika and dengue could cost just $1

Biden administration plans revamp of organ transplant system

entertainment

Wikipedia

knowledge

New air purifier tech could be key to improving indoor air quality

Teladoc has a new CEO, but challenges remain the same

What does generative AI mean for health care? We asked experts

5 takeaways from STAT's examination of Zynex Medical

Hollywood unions extend contract negotiations for actors

Xenotransplantation trials will require adjusting expectations, experts say

As demand for Covid shots wanes, Moderna seeks its next success

Cheap, fast test for Zika and dengue could cost just $1

How to save PrEP access — and even expand it

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

entertainment

Senate panel passes drug pricing bills, but drops one PBM reform

Cheap, fast test for Zika and dengue could cost just $1

Coercive sterilizations revealed by STAT prompt outrage

Coercive sterilizations revealed by STAT prompt outrage

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

U.K. agency declines to back Eli Lilly’s Mounjaro for type 2 diabetes

knowledge

leisure time

knowledge

Wikipedia